17/04/2026
Through the production of essential protein therapies, NBI contributes to improved treatment access and better outcomes for individuals living with Haemophilia and other bleeding disorders. In alignment with this year’s theme, “Diagnosis: First Step to Care,” NBI remains committed to advancing care, raising awareness, and supporting those affected.